Viewing Study NCT00838656

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-04-26 @ 4:03 AM
Study NCT ID: NCT00838656
Status: UNKNOWN
Last Update Posted: 2013-09-17
First Post: 2009-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Sponsor: Warwick Medical School
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fallopian Tube Cancer View
None Ovarian Cancer View
None Primary Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ovarian carcinosarcoma View
None stage IIIA ovarian epithelial cancer View
None stage IIIB ovarian epithelial cancer View
None stage IIIC ovarian epithelial cancer View
None stage IV ovarian epithelial cancer View
None stage IIIA primary peritoneal cavity cancer View
None stage IIIB primary peritoneal cavity cancer View
None stage IIIC primary peritoneal cavity cancer View
None stage IV primary peritoneal cavity cancer View
None stage IIIA fallopian tube cancer View
None stage IIIB fallopian tube cancer View
None stage IIIC fallopian tube cancer View
None stage IV fallopian tube cancer View